Today: 10 June 2026
Tesla stock jumps on SpaceX merger chatter — what TSLA investors watch next
30 January 2026
1 min read

Tesla stock jumps on SpaceX merger chatter — what TSLA investors watch next

New York, Jan 30, 2026, 15:06 EST — Regular session

Tesla Inc shares jumped roughly 4% to $433.83 in afternoon trading Friday following reports that SpaceX is considering deals that might shake up parts of Elon Musk’s business empire. The rally came as the broader tech sector faltered, with the Invesco QQQ Trust Series 1 sliding about 1.2% and the SPDR S&P 500 ETF Trust dipping around 0.4%.

Tesla’s shares remain driven largely by long-term bets on self-driving and robotics, not just vehicle sales. So any sign of increased computing power, sharper management focus, or fresh funding routes can send the stock moving fast.

This comes at a tricky moment for Tesla’s narrative. Car sales are cooling off, yet the company is pushing investors to focus beyond that, aiming instead at robotaxis and humanoid robots—ambitious goals with uncertain timelines.

Reuters reported that SpaceX is in talks to merge with xAI ahead of an anticipated IPO. Bloomberg News added that SpaceX is also weighing a merger with Tesla. “A single entity would help to further align his attention and ample resources to one company,” said Andrew Rocco of Zacks Investment Research. Reuters

Gene Munster of Deepwater Asset Management told Reuters on Thursday that it’s “highly likely” xAI will end up linked to one of the two major parties. Dennis Dick from Stock Trader Network warned that a key risk for Tesla is Musk spreading himself too thin. Reuters noted that neither Musk nor the companies responded to requests for comment. Reuters

Tesla’s latest quarterly report revealed a 3% drop in fourth-quarter revenue to $24.9 billion compared with a year ago. Automotive revenue slid 11%, while energy generation and storage jumped 25%. Net income attributable to common stockholders declined to $840 million, or 24 cents per share on a U.S. GAAP basis. Total vehicle deliveries fell 16% to 418,227 units. The company said it began testing driverless robotaxis in Austin last December and started removing the safety monitor from select customer rides in January. Tesla also announced a deal to invest about $2 billion in xAI, expected to close in Q1, and confirmed Cybercab, Tesla Semi, and Megapack 3 are still on track for volume production in 2026.

Yet the stock moves on headlines lacking concrete details. No terms have been disclosed, and big corporate deals often drag on for months—or quietly dissolve.

Execution risk is also a factor. Robotaxis and robots draw attention, require hefty upfront investment, and aren’t foolproof. Should the car market weaken more, the room for mistakes shrinks quickly.

Wall Street is closed for the weekend, so traders will be waiting on any official statements or filings that shed light on the progress of talks. The real test arrives Monday morning, Feb. 2, when the stock must maintain Friday’s gains without new momentum.

Stock Market Today

  • Palantir Technologies (PLTR) Shares Seen Fairly Valued Amid Recent Decline
    June 10, 2026, 5:48 PM EDT. Palantir Technologies has seen its share price fall 13.2% over the past week and 21.3% year to date, following extraordinary gains in prior years. At $132.07 per share, Palantir trades slightly below its estimated intrinsic value of $145.11 based on a Discounted Cash Flow (DCF) analysis, suggesting a modest 9% discount. The company posted $2.69 billion in free cash flow over the past twelve months, with projections rising to $16.11 billion by 2030. Despite recent volatility tied to sentiment on artificial intelligence and software spending, Palantir remains fairly valued but not a clear bargain. Investors should monitor further market developments and valuation metrics to gauge future opportunities or risks.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Joby Aviation stock drops again as $1.2 billion capital raise puts dilution back in focus
Previous Story

Joby Aviation stock drops again as $1.2 billion capital raise puts dilution back in focus

Oracle stock price drops again as AI fears weigh; Air Force cloud order lands
Next Story

Oracle stock price drops again as AI fears weigh; Air Force cloud order lands

Go toTop